ProfileGDS4718 / 213765_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 39% 51% 89% 28% 54% 17% 15% 37% 69% 59% 35% 35% 16% 8% 18% 48% 69% 23% 7% 13% 59% 71% 30% 76% 33% 14% 62% 16% 58% 4% 5% 37% 51% 13% 45% 25% 16% 62% 16% 83% 36% 10% 57% 19% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9623539
GSM549102patient 115, normal, homogenized [OPG study]5.5789451
GSM549104patient 119, normal, homogenized [OPG study]9.0021489
GSM549108patient 138, normal, homogenized [OPG study]4.4950728
GSM549119patient 077, normal, homogenized [OPG study]5.7553854
GSM549133patient 032, cancer, homogenized [OPG study]3.9963817
GSM549139patient 042, cancer, homogenized [OPG study]3.9301115
GSM549099patient 107, normal, homogenized [OPG study]4.8704137
GSM549109patient 139, normal, homogenized [OPG study]6.742869
GSM549110patient 046, normal, homogenized [OPG study]6.0447159
GSM549114patient 063, normal, homogenized [OPG study]4.7117235
GSM549122patient 082, normal, homogenized [OPG study]4.765935
GSM549134patient 033, cancer, homogenized [OPG study]3.9859516
GSM549136patient 036, cancer, homogenized [OPG study]3.658618
GSM549140patient 044, cancer, homogenized [OPG study]4.0406818
GSM549111patient 047, normal, homogenized [OPG study]5.3853248
GSM549113patient 057, normal, homogenized [OPG study]6.772569
GSM549132patient 031, cancer, homogenized [OPG study]4.255323
GSM549137patient 038, cancer, homogenized [OPG study]3.673297
GSM549142patient 047, cancer, homogenized [OPG study]3.9716213
GSM549100patient 110, normal, homogenized [OPG study]6.0316859
GSM549107patient 135, normal, homogenized [OPG study]6.9250671
GSM549115patient 068, normal, homogenized [OPG study]4.4835530
GSM549116patient 072, normal, homogenized [OPG study]7.4322176
GSM549120patient 078, normal, homogenized [OPG study]4.6481333
GSM549131patient 030, cancer, homogenized [OPG study]3.8899414
GSM549118patient 074, normal, homogenized [OPG study]6.2483662
GSM549129patient 027, cancer, homogenized [OPG study]3.9919816
GSM549123patient 088, normal, homogenized [OPG study]5.9983258
GSM549124patient 006, cancer, homogenized [OPG study]3.560174
GSM549126patient 015, cancer, homogenized [OPG study]3.58365
GSM549128patient 025, cancer, homogenized [OPG study]4.8502237
GSM549103patient 117, normal, homogenized [OPG study]5.6044751
GSM549117patient 073, normal, homogenized [OPG study]3.905913
GSM549138patient 041, cancer, homogenized [OPG study]5.2501945
GSM549141patient 045, cancer, homogenized [OPG study]4.2919925
GSM549130patient 028, cancer, homogenized [OPG study]4.0067816
GSM549101patient 111, normal, homogenized [OPG study]6.2936762
GSM549105patient 128, normal, homogenized [OPG study]4.0094516
GSM549106patient 134, normal, homogenized [OPG study]8.4345583
GSM549112patient 048, normal, homogenized [OPG study]4.7755836
GSM549125patient 011, cancer, homogenized [OPG study]3.7962210
GSM549127patient 024, cancer, homogenized [OPG study]5.9665357
GSM549135patient 035, cancer, homogenized [OPG study]4.0490619